We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Nicolo Rivolta has been assisting clients through the H1B Visa process since 2022.

As of 2022, Nicolo Rivolta has succesfully submitted and recieved certification for 218 cases.

Nicolo Rivolta is located in New York, NY, and has represented 14 employers for the H1B Visa Process

269
Cases Handled
218
Cases Certified
81.04%
Approval

Cases Handled by Nicolo Rivolta

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-21145-340361 Certified - Withdrawn Software Developers Applications Other Computer Related Services Adara Inc 2023
I-200-22104-072994 Certified Software Developers Applications Medical Equipment And Supplies Manufacturing Roche Diagnostics Operations Inc 2022
I-200-21144-340126 Certified Software Developers Applications Medical Equipment And Supplies Manufacturing Roche Sequencing Solutions Inc 2021
I-200-20192-707823 Certified - Withdrawn Software Developers Applications Medical Equipment And Supplies Manufacturing Roche Sequencing Solutions Inc 2022
I-200-20111-502607 Certified Software Developers Applications Medical Equipment And Supplies Manufacturing Roche Sequencing Solutions Inc 2020
I-200-19317-144455 Certified Software Developers Applications Medical Equipment And Supplies Manufacturing Roche Sequencing Solutions Inc 2020
I-200-19310-128574 Certified Software Developers Applications Medical Equipment And Supplies Manufacturing Roche Sequencing Solutions Inc 2020
I-200-21347-760739 Certified Software Developers Applications Electromedical And Electrotherapeutic Apparatus Manufacturing Ventana Medical Systems Inc 2022
I-200-22090-026040 Certified Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2022
I-200-22088-016215 Certified Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2022